2024 2nd quarter earnings conference call

Written By Kevin Jirka

  • Reports record revenue of $16.5 million for the third quarter of 2023.

  • GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.

  • Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022.

Listen to replay
Kevin Jirka
Previous

IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Next

2024 1st quarter earnings conference call